Latest news with #CIHR
Cision Canada
05-08-2025
- Health
- Cision Canada
New Research Funding Will Help to Strengthen Canada's National School Food Program
Applications will be accepted until October 23 OTTAWA, ON, Aug. 5, 2025 /CNW/ - Employment and Social Development Canada (ESDC) and the Canadian Institutes of Health Research (CIHR) have partnered to launch a new school food-focused research funding opportunity, under the 2025-26 Partnering for Impact – Catalyst Grant. As the Government of Canada continues to implement the National School Food Program, this funding opportunity will make sure that strong research and real community needs will be the foundation for school food programs. These research partnerships will fill key gaps in data and knowledge related to school food programming in Canada. The goal is to build a strong, evidence-based program that helps improve health, learning, and access to nutritious food at school - ensuring every generation has the support they need to reach their full potential. ESDC will invest up to $1 million to support research teams in co-producing research on the impacts of school food programs in Canada. Additionally, CIHR will invest up to $300,000 to support research teams in co-producing research on the impacts of school food programs in Northern communities. For both funding sources, up to $150,000 is available per grant, for up to one year. Through these ESDC-funded grants, research teams will: determine the most pressing school food data and research gaps study how school food programs affect the health and well-being of children – especially for those facing barriers explore how school food programs are delivered and governed in different jurisdictions and contexts, including in accordance with the National School Food Policy Grant applications will be accepted until Thursday, October 23, 2025, at 12:00 pm EDT. The successful applicants will be announced by Spring 2026. For detailed information about eligibility and how to apply for both school food-related funding pools, please consult CIHR's funding opportunity page on ResearchNet. Quotes "To deliver real impact, a National School Food Program must be guided by data, community input, and proven outcomes. This research will inform decisions that will support the health and success of all children and youth in Canada." – The Honourable Anna Gainey, Secretary of State for Children and Youth "Investing in the health of Canadians is part of the Canadian Institutes of Health Research raison d'être. Our partnership with Employment and Social Development Canada allows us to fund more grants in an area of need, and spark partnerships and collaborations in support of research studying the impacts of the National School Food Program. CIHR looks forward to receiving and reviewing the applications. " – Dr. Paul Hébert, President, Canadian Institutes of Health Research Quick facts The Government of Canada is investing $1 billion over five years to implement a National School Food Program with provinces, territories and Indigenous partners. This investment is enhancing and expanding school food programs across Canada and providing real support to children and families. As of March 10, 2025, all provinces and territories had signed bilateral agreements with Canada under the Program. The National School Food Program is administered by three federal departments – Employment Social Development Canada, Indigenous Services Canada and Crown-Indigenous Relations and Northern Affairs Canada. CIHR is part of the Health Portfolio, which supports the Minister of Health in maintaining and improving the health of Canadians. Composed of 13 institutes, CIHR provides leadership and support to health researchers and trainees across Canada. This funding opportunity is led by CIHR's Knowledge Mobilization Strategies Unit, in partnership with ESDC, Canada's Strategy for Patient-Oriented Research, the Centre for Research on Pandemic Preparedness and Health Emergencies, the Institute of Health Services and Policy Research, the Institute of Neurosciences, Mental Health and Addiction, and the Institute of Population and Public Health. SOURCE Employment and Social Development Canada
Globe and Mail
26-07-2025
- Health
- Globe and Mail
Canada is hosting the world's biggest dementia conference for the first time in a decade. What's changed since then?
This week, researchers from around the globe are descending upon downtown Toronto to attend the Alzheimer's Association International Conference, the world's biggest and most influential meeting for dementia research. The gathering is a chance for the international dementia community to discuss the latest research in the field; it's also where significant breakthroughs are often unveiled. At a related event on Saturday, the Canadian Institutes of Health Research (CIHR) – Canada's health research funding agency – announced $44.8-million in new funding for dementia and aging-related research initiatives, including the creation of 16 teams that will study everything from Alzheimer's biomarkers to dementia in Indigenous populations. To set the stage for this year's conference, The Globe and Mail checked in with Jane Rylett, a professor at Western University and scientific director at the CIHR Institute of Aging, which hosted Saturday's event. The last time this global conference was held in Canada was in 2016, nearly a decade ago. How has the dementia research landscape changed since then? This is a really important inflection point. There is a new class of drugs, the antibody therapy, that came into the market within the last three or four years; they probably will be approved in Canada in the coming years. But while there's huge hope around it . . . right now, there's a lot of debate around if they're really beneficial. For certain people, they don't work at all; other people have negative side effects by creating inflammation in the brain. And the benefit-to-risk ratio is not great. So I think at this year's conference, it's going to be really important to hear about new findings with that. Something that's really gained momentum over the last few years is stepping back from the pharmacological approach to treatment and saying, 'What else can we do that will reduce the risk of developing dementia?' Health system urged to brace for major shift in dementia demographics The other thing that's changed is there's always been an 'amyloid hypothesis' of Alzheimer's disease, based on these toxic peptides that get made in the brain and clearly have a role in brain health and development of dementia. But during these nine years, there's been a much greater move towards understanding the role of those and recognizing that while they're still important, they're not the whole story. Now there's more openness to looking at other hypotheses about how brain health can be impacted during the life course and can lead to dementia. How should people feel about this present moment? Thinking back to 2012, the United States' health department set an ambitious goal to prevent and effectively treat Alzheimer's disease by 2025. But here we are today and that goal is far from met. When people or groups make those kinds of statements, it doesn't necessarily mesh with the complication of the thing. And then what happens is people see [the missed deadline] and think, well, it didn't happen. That's always the danger of doing something like that. The brain is a complex thing, it really is. The problem with something like Alzheimer's disease is it's so multi-faceted and it's a spectrum. There's so many areas of the brain that are impacted and the clinical presentation can look similar for people but what's happening in their brain, and where the degeneration is initiated, can be quite different. There's no one pill that you're going to have that's going to be able to change the course or alleviate the symptoms. So was it realistic to say in 2012 that this could be cured by 2025? Probably not. But it stimulated a lot of activity. We understand much more about the underlying pathology and the pathogenesis of the disease. And stepping back was an important thing, saying what can we do that is not a pharmaceutical or a pill? What are the life, behavioural and other things that we can do? Canada has a chance to change the Alzheimer's experience - let's not squander it There's been a lot of focus on the funding cuts in the U.S. that are under way right now, including to the National Institutes of Health (NIH). How has that affected things? is it looming over the conference this year? Yes. A number of Canadian researchers also have been funded by NIH, either in their own right or as subcontracts on larger studies within the U.S., and for the most part, that has been ended, which is very problematic. So we have a number of very good Canadian researchers in all fields that have lost substantial funding, and we don't have the resources in Canada to replace that. One of the big question marks is the impact it's going to have on the number of Americans that are going to be able to attend the conference. And I don't know the answer to that yet. Let's talk about Canadian researchers. What role are they playing within the broader effort? Canadian researchers are leaders internationally in these fields of study. There's really significant work being done by Canadians in the biomarkers area, so the diagnostic area. We have a lot of expertise around how to develop and promote new methods for supporting caregivers and persons with dementia. Alzheimer's trial brings at-risk patients hope for the future, but new doubts in the present We've got outstanding Indigenous cognitive health researchers that are developing new culturally safe and appropriate diagnostic and caregiving methods. And we do have some very good work going on around pathogenesis, looking at changes in the brain during aging and how that may lead to loss of cognition. That's important because you really need to understand where those earliest changes come from. Those are the targets where you need to develop drugs and therapies. This interview has been edited and condensed.
Medscape
25-06-2025
- Health
- Medscape
Partnership Promotes Indigenous Mothers' Reproductive Health
Canada's Indigenous History Month is an appropriate time to examine the efforts that the Canadian Institutes of Health Research (CIHR) are taking to improve Indigenous health trajectories within the First Nations, Inuit, and Métis communities. Many of these efforts flow through the agency's Indigenous Healthy Life Trajectories Initiative (I-HeLTI), which is dedicated to creating transparent, community-first approaches to research and healthcare delivery. 'The goal of I-HeLTI is to identify culturally strengthening strategies crucial for improving maternal and child health outcomes in Indigenous communities,' Chelsea Gabel, PhD, scientific director of the Institute of Indigenous Peoples' Health at CIHR and associate professor of Indigenous studies and health, aging, and society at McMaster University in Hamilton, Ontario, told Medscape Medical News. Gabel is a Red River Métis. Chelsea Gabel, PhD 'Research shows that First Nations, Inuit, and Métis people experience significantly higher rates of noncommunicable diseases, as well as issues around maternal health and poor health outcomes in general,' she said. Research on Indigenous communities historically has focused on deficits. 'This means that it's focused on a larger problem (eg, Indigenous people are more likely to have diabetes or drink more) vs looking at [the role played by] factors like intergenerational trauma, the residential schools system, and social determinants of health.' I-HeLTI aims to change this focus. Community-Integrated Care I-HeLTI is based on a Developmental Origins of Health and Disease approach, which suggests that environmental factors (namely social determinants of health like poverty, racism, housing, and geographical location) interact with genes during conception, the pre- and postnatal and infancy periods, and early childhood to affect later health outcomes. The initiative has an international component in countries like China, India, and South Africa, as well as the World Health Organization. Several Indigenous projects are active in Canada, including Aunties Within Reach (AWR) in the Wood Buffalo region in Alberta. AWR is a collaborative partnership between the University of Alberta's Collaborative Applied Research for Equity in Health Policy and Systems (CARE) Lab and the Ihkapaskwa Collective. The CARE Lab is an applied health policy systems team that studies and designs, implements, and evaluates programs with community partners to develop locally tailored, context-based solutions. The Ihkapaskwa Collective is an Indigenous-founded and Indigenous-led nonprofit focused on providing accessible, community-centered reproductive healthcare. 'AWR is an excellent model of community-integrated care,' said Stephanie Montesanti, PhD, associate professor of public health at the University of Alberta, Edmonton, and head of the CARE Lab. The partnership is not only delivering reproductive health services directly in the community but also engaging with providers across health and social sectors, she explained. Stephanie Montesanti, PhD When Montesanti joined I-HeLTI, she wanted to explore the opportunity to bring the program to the Wood Buffalo regional municipality, where Sheena Bradley, Ihkapaskwa founder and executive director, had been working. Sheena Bradley Bradley, a Cree-Métis full-spectrum birth worker and clinical herbalist, cofounded AWR with Maddie Amyotte, a Cree-Métis registered Indigenous midwife, and Shelby Weiss, a Sturgeon Bay Cree full-spectrum birth worker. Bradley said that AWR provides reproductive health support that mirrors the way that traditional 'aunties' would, when and where mothers, families, and the community needed it most. But funding has been tight. 'The CARE Lab reached out to us to partner on the I-HeLTI initiative, and we spent a good portion of a year building relationships and learning what the research would look like in our community,' said Bradley. 'Would it be led by us and families and elders in the community?' she said. 'There's a few elders on that team from various communities that are really helping guide [the CARE Lab's] research and what they see fits as research being brought into the community,' said Bradley. 'But there's also natural guidance from our grandmothers, the elders that we work with every day, and the families we support. That's what is meant by the phrase 'guided by community.'' The goal was to bridge the gap and improve access to reproductive health services, said Montesanti. Indigenous Birth Practices Since the 1960s, Canada has relied on maternal evacuation, which transfers Indigenous pregnant women from Canada's rural, remote regions to urban hospitals to give birth. The strategy was created to address disparities in maternal and child outcomes. It has been linked, however, to emotional, social, and cultural harms, as well as maternal and neonatal infections. 'Within our municipality, which is massive in land size and home to 13 First Nations and Métis communities, a lot of mothers are evacuated for birth, leave their home community and their support systems to come into town, where they are then scrutinized for not having healthy supports,' said Bradley. 'As soon as they leave their nation and go into town to deliver their baby, they are placed under Provincial rather than Tribal Child Family Services. It's hard to navigate between the two and figure out who's responsible for who and what,' she added. 'You can imagine when people are coming from a remote community to an urban center and hospital setting, it's going to be uncomfortable.' 'These services are offered by the mainstream health system, which is not necessarily culturally safe or culturally relevant,' added Montesanti. On the other hand, full-spectrum birth workers are both aunties and care providers. 'They play important roles around social, cultural, and outreach support, as well as [providing] mentorship and traditional teachings related to reproductive health, like breast or infant feeding, postpartum care, mental health and well-being, and social well-being,' she explained. The CARE Lab ensures an ongoing cycle of implementation learning (ie, identifying best practices, linking volunteers to them, identifying similar programs that have been implemented in other contexts, and bringing the lessons they offer to AWR). In alignment with I-HeLTI requirements, the lab also is creating a pregnancy cohort. AWR is stretched to capacity. In addition to Bradley and Amyotte, a Métis nurse practitioner runs a private primary care practice and has hospital privileges in Fort McMurray. Carlee Myette, a Métis auntie navigator or all-around advocate, guides families through basic needs supports like housing, food, mental health referrals, and navigating Child and Family Services. Kaylen Duke, a Chipewyan Prairie Dene, is community engagement coordinator and research assistant and operates as a liaison between the Aunties and the CARE Lab team, which, in addition to Montesanti, includes research assistant Nicole Orji, a First Nations Iroquois. Kaylen Duke 'What can be a model for other communities is the fact that AWR is helping to reclaim traditional practices and knowledge; it's bringing culture and ceremony back to birth,' said Orji. 'Many of our nations are matrilineal. Through the process of reconciliation and the mainstream Western medicine model, we have lost not just our mothers, but Indigenous people in general have lost our autonomy, choices, rights, and control over our reproductive freedoms,' she said. 'A lot of the work that the Aunties Within Reach program is doing is repairing some of those harms,' said Orji. Nicole Orji Gabel, Montesanti, Orji, Bradley, and Duke reported having no relevant financial relationships.
National Post
23-05-2025
- Business
- National Post
Canada $5.79 Bn Legal Cannabis Market Share, Trends Analysis and Growth Forecasts, 2025-2030: New Educational Initiatives Propel Awareness, Rising Use of CBD for Anxiety, Pain, and Seizures
Article content Article content Article content DUBLIN — The 'Canada Legal Cannabis Market Size, Share, and Trends Analysis Report by Source (Marijuana, Hemp), Derivatives (CBD, THC), Cultivation, End-use (Medical, Recreational, Industrial), with Growth Forecasts, 2025-2030' report has been added to offering. Article content The Canada Legal Cannabis Market was valued at USD 3.25 Billion in 2024, and is projected to reach USD 5.79 Billion by 2030, rising at a CAGR of 12.00% Article content Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high demand for CBD for health and wellness purposes, attributed to its therapeutic properties, is a key driver in the market's growth. Article content Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, in February 2024, researchers at the University of British Columbia introduced a first-of-its-kind clinical trial examining the potential of CBD as a treatment for bipolar depression. The trials were approved by Health Canada and funded by the Canadian Institutes of Health Research (CIHR) to investigate how CBD can help manage acute bipolar depression. Article content Moreover, medical professionals' increasing preference for cannabinoid-based formulations to treat numerous health conditions is another major factor supporting the country's market. Healthcare professionals' higher preference for CBG, CBN-derived products creates a positive influence on consumer minds, thereby boosting their adoption rate and popularity. For instance, in October 2021, Cronos Group Inc. launched its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy that features THC and cultured CBG. Article content Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Maricann, Inc. These market players adopt key strategic initiatives to expand their business footprint and market position. For instance, in April 2023, Aurora Cannabis Inc. partnered with Strainprint and announced the launch of the tracking program through Strainprint App. The tracking program is designed for Aurora patients to keep track of their medical cannabis journey. Article content Furthermore, the rise in awareness regarding cannabis and its potential use in various industries and the introduction of educational programs boost the market growth. For instance, in July 2022, Tilray Brands launched a cannabis education platform, WeCare-Medical Cannabis. The platform is dedicated to educating patients and healthcare practitioners about medical cannabis. Article content Based on source, the marijuana segment dominated the market in 2025 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana-based products Based on derivatives, the CBD segment held the largest market share in 2025, owing to the awareness regarding CBD's effectiveness in treating various medical conditions Based on cultivation, the indoor segment held the largest market share in 2025 due to the incorporation of artificial intelligence (AI) in cannabis cultivation, rising investments, and favorable government initiatives Based on end use, the recreational segment dominated the market in 2025 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing consumption of cannabis in the form of vapes, foods, and beverages Article content Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Article content Chapter 1. Methodology and Scope Article content Chapter 2. Executive Summary Article content 2.1. Market Outlook Article content 2.2. Segment Outlook Article content 2.2.1. Source outlook Article content 2.2.2. Derivatives outlook Article content 2.2.3. Cultivation outlook Article content 2.2.4. End Use outlook Article content 2.3. Competitive Insights Article content Chapter 3. Canada Legal Cannabis Market Variables, Trends & Scope Article content 3.1. Market Lineage Outlook Article content 3.1.1. Parent market outlook Article content 3.1.2. Ancillary market outlook Article content 3.2. Market Dynamics Article content 3.2.1. Market driver analysis Article content 3.2.2. Market restraint analysis Article content 3.3. Canada Legal Cannabis: Market Analysis Tools Article content 3.3.1. Industry Analysis – Porter's Article content 3.3.2. PESTLE Analysis Article content 3.4. Regulatory Framework Article content Chapter 4. Canada Legal Cannabis Market Segment Analysis, by Source, 2018-2030 (USD Million) Article content 4.1. Definition and Scope Article content 4.2. Product Market Share Analysis, 2024 & 2030 Article content 4.3. Segment Dashboard Article content 4.4. Canada Legal Cannabis market, by Source, 2018 to 2030 Article content 4.5. Marijuana Article content 4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million) Article content 4.5.2. Flowers Article content 4.5.3. Oil and Tinctures Article content 4.6. Hemp Article content 4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million) Article content 4.6.2. Hemp Oil Article content 4.6.3. Industrial Hemp Article content Chapter 5. Canada Legal Cannabis Market Segment Analysis, by Derivatives, 2018-2030 (USD Million) Article content 5.1. Definition and Scope Article content 5.2. Derivatives Market Share Analysis, 2024 & 2030 Article content 5.3. Segment Dashboard Article content 5.4. Canada Legal Cannabis market, by Derivatives, 2018 to 2030 Article content 5.5. CBD Article content 5.6. THC Article content 5.7. Other derivatives Article content Chapter 6. Canada Legal Cannabis Market Segment Analysis, by Cultivation, 2018-2030 (USD Million) Article content 6.1. Definition and Scope Article content 6.2. Cultivation Market Share Analysis, 2024 & 2030 Article content 6.3. Segment Dashboard Article content 6.4. Canada Legal Cannabis market, by Cultivation, 2018 to 2030 Article content 6.5. Indoor Cultivation Article content 6.6. Greenhouse Cultivation Article content 6.7. Outdoor Cultivation Article content Chapter 7. Canada Legal Cannabis Market Segment Analysis, by End Use, 2018-2030 (USD Million) Article content 7.1. Definition and Scope Article content 7.2. End Use Market Share Analysis, 2024 & 2030 Article content 7.3. Segment Dashboard Article content 7.4. Global Canada Legal Cannabis Market, by End Use, 2018 to 2030 Article content 7.5. Medical Use Article content 7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) Article content 7.5.2. Cancer Article content 7.5.3. Chronic Pain Article content 7.5.4. Depression and Anxiety Article content 7.5.5. Arthritis Article content 7.5.6. Diabetes Article content 7.5.7. Glaucoma Article content 7.5.8. Migraine Article content 7.5.9. Epilepsy Article content 7.5.10. Multiple Sclerosis Article content 7.5.11. AIDS Article content 7.5.12. Amyotrophic Lateral Sclerosis Article content 7.5.13. Alzheimer's Article content 7.5.14. Post Traumatic Stress Disorder (PTSD) Article content 7.5.15. Parkinson's Article content 7.5.16. Tourette's Article content 7.5.17. Others Article content 7.6. Recreational Use Article content 7.7. Industrial Use Article content Chapter 8. Competitive Landscape Article content 8.1. Recent Developments & Impact Analysis, by Key Market Participants Article content 8.2. Company Categorization Article content 8.3. Company Profiles Article content Canopy Growth Corporation Charlotte's Web, Inc. Aurora Cannabis Inc. Tilray Brands The Cronos Group Jazz Pharmaceuticals, Inc. Organigram Holding, Inc. Maricann, Inc. Isodiol International, Inc Sundial Growers Article content is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Article content Article content Article content Article content Article content Contacts Article content Article content Article content
Yahoo
22-05-2025
- Business
- Yahoo
Canada Legal Cannabis Industry Report 2025-2030: Industry Leaders like Canopy Growth and Tilray Brands Steer Market Expansion
Canada's legal cannabis market, valued at USD 3.25 Billion in 2024, is projected to reach USD 5.79 Billion by 2030, growing at a 12% CAGR. Key drivers include health benefits awareness, increasing clinical trials, and product innovation. . Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Canada Legal Cannabis Market Size, Share, and Trends Analysis Report by Source (Marijuana, Hemp), Derivatives (CBD, THC), Cultivation, End-use (Medical, Recreational, Industrial), with Growth Forecasts, 2025-2030" report has been added to Canada Legal Cannabis Market was valued at USD 3.25 Billion in 2024, and is projected to reach USD 5.79 Billion by 2030, rising at a CAGR of 12.00% Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high demand for CBD for health and wellness purposes, attributed to its therapeutic properties, is a key driver in the market's the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, in February 2024, researchers at the University of British Columbia introduced a first-of-its-kind clinical trial examining the potential of CBD as a treatment for bipolar depression. The trials were approved by Health Canada and funded by the Canadian Institutes of Health Research (CIHR) to investigate how CBD can help manage acute bipolar medical professionals' increasing preference for cannabinoid-based formulations to treat numerous health conditions is another major factor supporting the country's market. Healthcare professionals' higher preference for CBG, CBN-derived products creates a positive influence on consumer minds, thereby boosting their adoption rate and popularity. For instance, in October 2021, Cronos Group Inc. launched its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy that features THC and cultured of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Maricann, Inc. These market players adopt key strategic initiatives to expand their business footprint and market position. For instance, in April 2023, Aurora Cannabis Inc. partnered with Strainprint and announced the launch of the tracking program through Strainprint App. The tracking program is designed for Aurora patients to keep track of their medical cannabis the rise in awareness regarding cannabis and its potential use in various industries and the introduction of educational programs boost the market growth. For instance, in July 2022, Tilray Brands launched a cannabis education platform, WeCare-Medical Cannabis. The platform is dedicated to educating patients and healthcare practitioners about medical Legal Cannabis Market Report Highlights Based on source, the marijuana segment dominated the market in 2025 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana-based products Based on derivatives, the CBD segment held the largest market share in 2025, owing to the awareness regarding CBD's effectiveness in treating various medical conditions Based on cultivation, the indoor segment held the largest market share in 2025 due to the incorporation of artificial intelligence (AI) in cannabis cultivation, rising investments, and favorable government initiatives Based on end use, the recreational segment dominated the market in 2025 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing consumption of cannabis in the form of vapes, foods, and beverages Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.2.1. Source outlook2.2.2. Derivatives outlook2.2.3. Cultivation outlook2.2.4. End Use outlook2.3. Competitive InsightsChapter 3. Canada Legal Cannabis Market Variables, Trends & Scope3.1. Market Lineage Outlook3.1.1. Parent market outlook3.1.2. Ancillary market outlook3.2. Market Dynamics3.2.1. Market driver analysis3.2.2. Market restraint analysis3.3. Canada Legal Cannabis: Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTLE Analysis3.4. Regulatory FrameworkChapter 4. Canada Legal Cannabis Market Segment Analysis, by Source, 2018-2030 (USD Million)4.1. Definition and Scope4.2. Product Market Share Analysis, 2024 & 20304.3. Segment Dashboard4.4. Canada Legal Cannabis market, by Source, 2018 to 20304.5. Marijuana4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)4.5.2. Flowers4.5.3. Oil and Tinctures4.6. Hemp4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)4.6.2. Hemp Oil4.6.3. Industrial HempChapter 5. Canada Legal Cannabis Market Segment Analysis, by Derivatives, 2018-2030 (USD Million)5.1. Definition and Scope5.2. Derivatives Market Share Analysis, 2024 & 20305.3. Segment Dashboard5.4. Canada Legal Cannabis market, by Derivatives, 2018 to 20305.5. CBD5.6. THC5.7. Other derivativesChapter 6. Canada Legal Cannabis Market Segment Analysis, by Cultivation, 2018-2030 (USD Million)6.1. Definition and Scope6.2. Cultivation Market Share Analysis, 2024 & 20306.3. Segment Dashboard6.4. Canada Legal Cannabis market, by Cultivation, 2018 to 20306.5. Indoor Cultivation6.6. Greenhouse Cultivation6.7. Outdoor CultivationChapter 7. Canada Legal Cannabis Market Segment Analysis, by End Use, 2018-2030 (USD Million)7.1. Definition and Scope7.2. End Use Market Share Analysis, 2024 & 20307.3. Segment Dashboard7.4. Global Canada Legal Cannabis Market, by End Use, 2018 to 20307.5. Medical Use7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)7.5.2. Cancer7.5.3. Chronic Pain7.5.4. Depression and Anxiety7.5.5. Arthritis7.5.6. Diabetes7.5.7. Glaucoma7.5.8. Migraine7.5.9. Epilepsy7.5.10. Multiple Sclerosis7.5.11. AIDS7.5.12. Amyotrophic Lateral Sclerosis7.5.13. Alzheimer's7.5.14. Post Traumatic Stress Disorder (PTSD)7.5.15. Parkinson's7.5.16. Tourette's7.5.17. Others7.6. Recreational Use7.7. Industrial UseChapter 8. Competitive Landscape8.1. Recent Developments & Impact Analysis, by Key Market Participants8.2. Company Categorization8.3. Company Profiles Canopy Growth Corporation Charlotte's Web, Inc. Aurora Cannabis Inc. Tilray Brands The Cronos Group Jazz Pharmaceuticals, Inc. Organigram Holding, Inc. Maricann, Inc. Isodiol International, Inc Sundial Growers For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
